NSCLC patients parameter
| |
Plasma FL
| |
---|
Data
|
Lowb (n = 36)
|
Highb (n = 34)
|
P valuec
|
---|
Plasma FL, μg/mL AGE-BSA
|
M
|
0.81 (0.73–0.95)
|
1.29 (1.21–1.61)
|
<0.001
|
Age, y
|
M
|
69 (60–72)
|
68 (60–73)
|
0.797
|
Gender
| | | | |
Male
|
n
|
31
|
22
|
0.071
|
Female
|
n
|
5
|
12
| |
Body mass index
|
M
|
26 (24–28)
|
27 (24–29)
|
0.813
|
NSCLC histology
| | | | |
ADCd
|
n
|
11
|
19
|
0.059
|
SCCe
|
n
|
21
|
12
| |
Others
|
n
|
4
|
4
| |
Tumor (T) stage
| | | | |
T1
|
n
|
5
|
12
|
0.113
|
T2
|
n
|
20
|
14
| |
T3-4
|
n
|
11
|
8
| |
Nodal (N) stage
| | | | |
N0
|
n
|
15
|
21
|
0.290
|
N1
|
n
|
9
|
6
| |
N2
|
n
|
11
|
7
| |
Resection (R) stage
| | | | |
R0
|
n
|
31
|
33
|
0.199
|
R1
|
n
|
5
|
1
| |
Smoker
| | | | |
Current
|
n
|
18
|
12
|
0.199
|
Former
|
n
|
12
|
16
| |
None
|
n
|
6
|
6
| |
Diabetes mellitus
| | | | |
Yes
|
n
|
10
|
9
|
1.000
|
No
|
n
|
26
|
29
| |
Blood glucose, mmol/L
|
M
|
5.5 (4.9–7.0)
|
5.3 (4.9–6.9)
|
0.812
|
Renal failure
| | | | |
Yes
|
n
|
3
|
4
|
1.000
|
No
|
n
|
33
|
30
| |
Blood creatinine, μmol/L
|
M
|
79 (69–85)
|
77 (70–85)
|
0.897
|
Blood urea, mmol/L
|
M
|
5.3 (4.6–6.5)
|
5.7 (4.6–6.3)
|
0.668
|
- aData are either given as median (M) with interquartile range or as number of NSCLC patients (n).
- bCutoff point at the median plasma FL of all NSCLC patients (1.08 µg/mL AGE-BSA).
- cP values were calculated by use of the Student t test (median differences) or the χ2 test (homogeneity of variances) as appropriated.
- dADC, adenocarcinoma.
- eSCC, squamous cell carcinoma.